Sighture Medical secured strategic agreements at the 32nd Western China Health Industry Expo (March 7-9, 2025), where its GAITNOVATE biomechanical systems and MedEye Simulated Eye attracted major Asian buyers. Key achievements include partnerships with Japanese orthopedic innovators and procurement interest from Russian/Indian healthcare providers.
Core Exhibits
GAITNOVATE-III System
Showcased 12,288-sensor gait analysis for diabetic foot prevention (±2% accuracy, 200kg capacity)
Demonstrated new ACL rehabilitation protocols
MedEye Simulated Eye
Vitreoretinal surgery training platform with 120Hz performance analytics
Realistic anatomical models for Japanese residency programs
Strategic Outcomes
Japan: Signed MOU with Osaka’s OrthoFit to develop sensor-embedded therapeutic socks using GAITNOVATE pressure data
Russia: Procurement proposals for 22 GAITNOVATE-II units from Moscow rehab centers
India: Advanced talks with Apollo Hospitals for 8-city deployment
Domestic: 89 clinical trial requests from Tier-1 hospitals
"Our Simulated Eye bridges surgical training gaps," stated CEO Yang Yupeng. "Combined with OrthoFit’s wearable tech, we’re creating closed-loop solutions from diagnosis to recovery."
Next Steps
Q2 2025: Co-development launch of smart orthopedic wearables with OrthoFit
Q3 2025: Customized MedEye modules for Japanese surgical standards
2026: Production scale-up for CIS/India markets
*ISO 13485-certified with 32 patents. Serving 46 countries through sensor-driven medical ecosystems.*
English 
